Overview
AbbVie is a research-based biopharmaceutical company in North Chicago, Illinois, that treats chronic autoimmune diseases in rheumatology, gastroenterology and dermatology, as well as cancers, viral infections, neurological disorders such as Parkinson’s disease and other conditions.[2] Forbes records sales of US$62.8bn, up 9.5% on the prior-year figure, which kept it in sixth place.[2] Profit of US$3.6bn gives a margin of under 6%, the lowest among the profitable US companies in the list, while its market value of US$371.7bn is the third highest in the ranking.[2] The gap between modest reported profit and a high valuation reflects non-cash charges and investor expectations rather than operating weakness. Forbes notes the company’s founding date as 19 October 2011, before its separation from Abbott Laboratories, which Forbes classifies separately as a medical-equipment company.[2]
AbbVie strengths and limitations
Strengths
- Sales growth of 9.5%
- Third-highest market value in the ranking
- Strong presence in autoimmune disease
Limitations
- Profit margin under 6% on Forbes data
- Dependent on a small number of immunology brands
- Heavy acquisition-related charges
Appears in
AbbVie peers and competitors
Companies ranked in the same lists as AbbVie.
Johnson & Johnson
Takeda Pharmaceutical
Daiichi Sankyo- Astellas Pharma
Viatris- Regeneron Pharmaceuticals
- CSL
Otsuka Holdings- Teva Pharmaceutical
Merck KGaA
Gilead Sciences- Amgen
Is this your company?
Update the description, logo, image and link through the submission form. Editors review every change.